ImmunoGenesis Inc.
ImmunoGenesis Inc.
Categories
Biotechnology
About
ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms. Because these “cold” tumors (the majority of cancers) are resistant to immunotherapy, our team strives to create sophisticated therapies that target key mechanisms of immune resistance. We look at cold tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.